Back to search results

Web-based Insomnia Treatment for Black/African American Prostate Cancer Survivors

This pilot study is looking at web-based treatments for insomnia in Black/African American men who have survived prostate cancer. It compares two interventions: "Sleep Healthy Using the Internet (SHUTi)," which is an online cognitive behavioral therapy (CBT) for insomnia, and an educational website about insomnia. The study aims to see if SHUTi is practical to use and acceptable to participants, and how it compares to the educational website in improving sleep and overall well-being. You may be able to join if you are a Black/African American man, at least 21 years old, diagnosed with prostate cancer within the last 5 years, and have not had recent surgery, chemotherapy, or radiation. You also need reliable internet access or be willing to attend weekly study appointments. The study plans to enroll 40 participants, but its current recruitment status is unclear.

Study design
This is an interventional study that will randomize 40 participants to one of two treatments: SHUTi or an educational website.
What's involved
You would either need a smartphone, tablet, or computer with reliable internet access, or be willing to attend a weekly study appointment and complete a weekly phone call.
Compensation
Not stated in the trial record.
Follow-up
The feasibility and acceptability of the interventions will be measured at 10-12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07128927

Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

Recruiting
NAAges 21+InterventionalTreatment
Georgetown University
~40 participants
Updated 2025-12-05 on ClinicalTrials.gov
What's tested:Sleep Healthy Using the Internet (SHUTi)Patient education

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of study protocol
Measured over 10-12 weeks
+1 more outcome measured

Conditions

Insomnia

Explore related trials

InsomniaProstate Carcinoma

Where it's being run

1 sites across 1 states
District of Columbia1

Who to contact

Traci Bethea
[email protected]
202-687-5367
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥21 years
Self-identifies as Black/African American
Diagnosed with invasive prostate cancer (AJCC stages I-IV) within 5 years
Has not received surgery, chemotherapy, or radiation within the previous 3 months
Has a smart phone, tablet, or computer with reliable internet access or willing to attend a weekly study appointment and to complete a weekly phone call
Has clinically relevant insomnia symptoms (i.e., score ≥10 on the Insomnia Severity Index)
Able to read and understand English

Exclusion

Employed in an occupation where sleep restriction could be a harm to themselves or others
Actively employed in shift work
Diagnosed with a severe/major psychiatric disorder
Diagnosed with a seizure disorder or recently (≤12 months) experienced a seizure
Unable to consent

What this trial measures

  • Feasibility of study protocol10-12 weeks

    Assessed via: * the percentage of survivors screened as eligible who consent to participate, * the percentage of actual vs. planned participants enrolled, and * the percentage of enrolled participants complete follow-up data collection

  • Acceptability of intervention10-12 weeks

    Assessed via the theoretical framework of acceptability questionnaire (range: 5-35, higher score = greater acceptability)